|

Alzheimer's Disease Clinical Trials in Nashville, TN

15 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)—<1 mi
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesPhase 3<1 mi
Tennessee Alzheimer's Project—<1 mi
Trial-Ready Cohort-Down Syndrome (TRC-DS)—<1 mi
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseasePhase 2<1 mi
Swallowing Impairments in Adults With and Without Alzheimer's Disease—<1 mi
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)Phase 3<1 mi
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADPhase 3<1 mi
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Phase 3<1 mi
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)Phase 1/2<1 mi
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseasePhase 3<1 mi
Vanderbilt Memory and Aging Project—<1 mi
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)Phase 317 mi
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 PhaseN/A31 mi
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)Phase 241 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.